Skip to main content
About Us > Jason E. Barkeloo

Jason E. Barkeloo

Founder and CEO

Jason E. Barkeloo is the Founder and CEO of Open Therapeutics. His motto is, “It’s not why we can’t. It’s how we can.” Barkeloo is a serial entrepreneur with a strong reputation for building sound businesses and transitioning them to professional management. ┬áHe leads the technology and intellectual property development, including blockchain integration into the Therapoid open science collaboration platform.

His two enterprises prior to Open Therapeutics were Pilus Energy, a synthetic bacterial based platform which he sold to a reputable company, and Somatic Digital, a human/computer interface company that developed the Touch User Interface (TUI). His entrepreneurial ventures include several technologies for education and financial services. Mr. Barkeloo has served in the US Army both in air defense and medical laboratory operations. He has a Bachelor of Arts from The Ohio State University, a Master of Arts in Education specializing in sciences and social studies from the McGregor School of Antioch University, and Ph.D. coursework in Leadership and Organizational Change from Antioch University.

We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is advancing research that ordinarily has not generated a public value or been recognized. This approach particularly helps underserved scientists to collaborate with their more financially capable colleagues.

How open science helps researchers succeed:

Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers.

The review of the literature demonstrates that open science is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open science practices bring significant benefits to researchers relative to more traditional closed practices.

Secured By miniOrange